Beyond suppression: the paradox of JAK inhibitors as amplifiers of cancer immunotherapy
{{output}}
JAK inhibitors target a large group of cytokines that signal through the JAK-STAT pathway and are typically used clinically as immunosuppressive agents. However, recent work has demonstrated the paradoxical ability of JAK inhibitors to enhance antitumour and a... ...